Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Vaccine|September 30, 2008
Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adultsRoderick S Tang, Richard R Spaete, Mark W Thompson, et al.Bioorganic & Medicinal Chemistry Letters|December 18, 2004
(S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activityAlexandre L'Heureux, Alain Martel, Huan He, et al.BMC Neuroscience|November 9, 2010
Viable mouse gene ablations that robustly alter brain Aβ levels are rareJeremy H Toyn, Xu-Alan Lin, Mark W Thompson, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and KCNQ2 opener activity of N-(1-benzo[1,3]dioxol-5-yl-ethyl, N-[1-(2,3-dihydro-benzofuran-5-yl)-ethyl, and N-[1-(2,3-dihydro-1H-indol-5-yl)-ethyl acrylamidesYong-Jin Wu, Li-Qiang Sun, Huan He, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2013
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic painYong-Jin Wu, Charles M Conway, Li-Qiang Sun, et al.Journal of Medicinal Chemistry|July 11, 2003
(S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraineYong-Jin Wu, Christopher G Boissard, Corinne Greco, et al.The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.Pageof 2